Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...
Researchers discovered that gut microbiota-derived hexa-acylated LPS enhances the effectiveness of anti-PD-1 cancer ...
The tumor microenvironment (TME) in solid tumors contains myeloid cells that modulate local immune activity. STING signaling activation in these myeloid cells enhances local type I interferon (IFN) ...
Within this stromal reaction, myeloid cells are a predominant population. Distinct myeloid subsets have been correlated with tumour promotion and unmasking of anti-tumour immunity. Objective The goal ...
2 Institute of Molecular Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA 3 Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, ...
Being able to sensitively detect even a few residual leukemic cells provides a more comprehensive picture of the current AML status of a sample. OGT’s new highly targeted SureSeq Myeloid MRD Panel ...
Media measurement firm Nielsen will stop selling its stand-alone consumer panel-based TV ratings in the fourth quarter of this year, according to a memo sent from Nielsen to ad-buyers and ...
The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML). A research team from Columbia Engineering and ...
It essentially hacks the immune cells, transferring its own faulty mitochondrial DNA (mtDNA) into the T-cells meant to attack it. This sneaky move weakens the immune cells, making them less ...
The active ingredient digoxin, a substance found in foxglove, reduces the number of cells in clusters of breast cancer cells circulating in the blood. These clusters are responsible for the formation ...
1 Being able to sensitively detect even a few residual leukemic cells provides a more comprehensive picture of the current AML status of a sample. OGT’s new highly targeted SureSeq Myeloid MRD Panel ...
Zhejiang Cancer Hospital, The Key Laboratory of Zhejiang Province for Nucleic Acids, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China ...